Seasonality and temporal correlation between community antibiotic use and resistance in the United States

Clinical Infectious Diseases

Volumn 55, Issue 5, 2012, Pages 687-694

  Sun, Lova ^a   Klein, Eili Y ^a,b   Laxminarayan, Ramanan ^a,b  

^a PRINCETON UNIVERSITY   (United States)

^b Center for Disease Dynamics Economics and Policy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; LINCOSAMIDE; MACROLIDE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; DRUG USE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SEASONAL VARIATION; UNITED STATES;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DATABASES, FACTUAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HUMANS; PREVALENCE; RETROSPECTIVE STUDIES; SEASONS; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 84864952631     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis509     Document Type: Article

References (40)

1. Niederman MS. Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit Care Med 2001; 29(4 suppl):N114-20.
2. Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 2010; 74:417-33.
3. Wang EE, Kellner JD, Arnold S. Antibiotic-resistant Streptococcus pneumoniae. Implications for medical practice. Can Fam Physician 1998; 44:1881-8.
4. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. PNAS 1999; 96:1152-6.
5. Granizo JJ, Aguilar L, Casal J, Dal-Re R, Baquero F. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother 2000; 46:959-64.
6. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a crossnational database study. Lancet 2005; 365:579-87.
7. Monnet DL, MacKenzie FM, Lopez-Lozano JM, et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis 2004; 10:1432-41.
8. Lopez-Lozano JM, Monnet DL, Yague A, et al. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. Int J Antimicrob Agents 2000; 14:21-31.
9. Hay AD, Thomas M, Montgomery A, et al. The relationship between primary care antibiotic prescribing and bacterial resistance in adults in the community: a controlled observational study using individual patient data. J Antimicrob Chemother 2005; 56:146-53.
10. Gottesman BS, Carmeli Y, Shitrit P, Chowers M. Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting. Clin Infect Dis 2009; 49:869-75.
11. Lepper PM, Grusa E, Reichl H, Hogel J, Trautmann M. Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2002; 46:2920-5.
12. Gallini A, Degris E, Desplas M, et al. Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital. J Antimicrob Chemother 2010; 65:2650-7.
13. Vernaz N, Huttner B, Muscionico D, et al. Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using populationbased data from a large hospital and its surrounding community. J Antimicrob Chemother 2011; 66:928-35.
14. Hicks LA, Chien Y-W, Taylor TH, Haber M, Klugman KP. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003. Clin Infect Dis 2011; 53:631-9.
15. Polgreen P, Yang M, Laxminarayan R, Cavanaugh J. Respiratory fluoroquinolone use and influenza. Infect Control Hosp Epidemiol 2011; 32:706-9.
16. Jaffe HW, Zaidi AA, Thornsberry C, Reynolds GH, Wiesner PJ. Trends and seasonality of antibiotic resistance of Neisseria gonorrhoeae. J Infect Dis 1977; 136:684-8.
17. Dagan R, Barkai G, Givon-Lavi N, et al. Seasonality of antibioticresistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy? J Infect Dis 2008; 197:1094-102.
18. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009; 7:629-41.
19. Campos J, Ferech M, Lazaro E, et al. Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J Antimicrob Chemother 2007; 60:698-701.
20. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 2007; 13:1840-6.
21. Hoffmann MS, Eber MR, Laxminarayan R. Increasing resistance of acinetobacter species to imipenem in United States hospitals, 1999- 2006. Infect Control Hosp Epidemiol 2010; 31:196-7.
22. Jones ME, Mayfield DC, Thornsberry C, Karlowsky JA, Sahm DF, Peterson D. Prevalence of oxacillin resistance in Staphylococcus aureus among inpatients and outpatients in the United States during 2000. Antimicrob Agents Chemother 2002; 46:3104-5.
23. Sahm DF, Marsilio MK, Piazza G. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database-USA. Clin Infect Dis 1999; 29:259-63.
24. Klein E, Smith DL, Laxminarayan R. Community-associated methicillin- resistant Staphylococcus aureus in outpatients, United States, 1999-2006. Emerg Infect Dis 2009; 15:1925-30.
25. Cleveland RB, Cleveland WS, McRae JE, Terpenning I. STL: a seasonal- trend decomposition procedure based on loess. J Official Stat 1990; 6:3-73.
26. Bowie C, Prothero D. Finding causes of seasonal diseases using time series analysis. Int J Epidemiol 1981; 10:87-92.
27. Lanska DJ, Hoffmann RG. Seasonal variation in stroke mortality rates. Neurology 1999; 52:984-90.
28. Monnet DL. Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control. Infect Control Hosp Epidemiol 1998; 19:552-9.
29. Box GEP, Jenkins GM, Reinsel GC. Time series analysis: forecasting and control, 3rd ed. Englewood Cliffs, NJ: Prentice Hall, 1994.
30. Helfenstein U. Box-Jenkins modelling in medical research. Stat Methods Med Res 1996; 5:3-22.
31. Auslander JN, Lieberman DA, Sonnenberg A. Lack of seasonal variation in the endoscopic diagnoses of Crohn's disease and ulcerative colitis. Am J Gastroenterol 2005; 100:2233-8.
32. Cromwell JB, Labys WC, Terraza M. Univariate tests for time series models. Thousand Oaks, CA: Sage Publications, 1994.
33. Wertheim HFL, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. The Lancet Infectious Diseases 2005; 5:751-62.
34. Klein EY, Sun L, Smith DL, Laxminarayan R. The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States. In press. Am J Epidemiol.
35. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002; 34:482-92.
36. Barber M, Waterworth PM. Antibacterial activity of lincomycin and pristinamycin: a comparison with erythromycin. Br Med J 1964; 2:603-6.
37. Kwong JC, Maaten S, Upshur RE, Patrick DM, Marra F. The effect of universal influenza immunization on antibiotic prescriptions: an ecological study. Clin Infect Dis 2009; 49:750-6.
38. Bauchner H, Pelton SI, Klein JO. Parents, physicians, and antibiotic use. Pediatrics 1999; 103:395-401.
39. Achermann R, Suter K, Kronenberg A, et al. Antibiotic use in adult outpatients in Switzerland in relation to regions, seasonality and point of care tests. Clin Microbiol Infect 2010; 17:855-61.
40. Polk RE, Johnson CK, McClish D, Wenzel RP, Edmond MB. Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities. Clin Infect Dis 2004; 39:497-503.